combretastatin has been researched along with oxazoles in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biersack, B; Effenberger, K; Knauer, S; Ocker, M; Schobert, R | 1 |
| Biersack, B; Mahal, K; Schobert, R | 1 |
| Chen, X; Jin, J; Xu, B; Yin, Y; Zhang, Y; Zhou, J | 1 |
| Biersack, B; Dittmer, A; Gosch, LC; Höpfner, M; Mueller, T; Rothemund, M; Schmitt, F; Schobert, R; Volkamer, A | 1 |
4 other study(ies) available for combretastatin and oxazoles
| Article | Year |
|---|---|
Ru(η6-arene) complexes of combretastatin-analogous oxazoles with enhanced anti-tumoral impact.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Cell Line, Tumor; Chick Embryo; Humans; Magnetic Resonance Spectroscopy; Oxazoles; Ruthenium; Spectrometry, Mass, Electrospray Ionization | 2010 |
New oxazole-bridged combretastatin A-4 analogues as potential vascular-disrupting agents.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Apoptosis; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Endothelial Cells; Flow Cytometry; HT29 Cells; Humans; Hybrid Cells; In Vitro Techniques; Oxazoles; Structure-Activity Relationship; Tubulin; Tubulin Modulators; Tumor Cells, Cultured | 2013 |
Synthesis and antiproliferative evaluation of novel benzoimidazole-contained oxazole-bridged analogs of combretastatin A-4.
Topics: Animals; Antineoplastic Agents; Benzimidazoles; Bibenzyls; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Flow Cytometry; Humans; Inhibitory Concentration 50; Mice; Models, Molecular; Molecular Structure; Oxazoles; Xenograft Model Antitumor Assays | 2013 |
Oxazole-Bridged Combretastatin A-4 Derivatives with Tethered Hydroxamic Acids: Structure⁻Activity Relations of New Inhibitors of HDAC and/or Tubulin Function.
Topics: Antineoplastic Agents; Bibenzyls; Binding Sites; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Histone Deacetylase Inhibitors; Humans; Hydrogen Bonding; Hydroxamic Acids; Inhibitory Concentration 50; Microtubules; Models, Molecular; Molecular Conformation; Molecular Structure; Oxazoles; Protein Binding; Structure-Activity Relationship; Tubulin; Tubulin Modulators | 2019 |